DWSN Q2 2019 Earnings EPS Misses Estimates Amid Challenging Market SCHL Q1 2026 Earnings EPS Beats Estimates as Scholastic Posts SmallerThanExpected Loss GSHD Q1 2026 Earnings Stellar EPS Surprise of 7944 Outpaces Estimates BOTJ Q1 2025 Earnings Net Income Per Share Holds Steady at 019 Amid Quiet Quarter ESPR Q1 2026 Earnings A BottomLine Miss as Investors Look for Growth Catalysts Allogene Therapeutics Edges Higher Testing Key Resistance at 21 Teleflex TFX Edges Higher Amid Consolidation Near Key Resistance Level Fulcrum Therapeutics FULC Hovers Near Support After Marginal Uptick Title Eastern Company EML Holds Steady at 2126 as Support and Resistance Levels Remain Key KALU Q1 2026 Earnings Massive EPS Surprise of 97 Drives Stock Higher